IperionX
IPX
IperionX (IPX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $55.00 from $40.00 | Jun 5, 2026 |
| BTIG | Initiated Coverage | Buy | $40.00 | Mar 27, 2026 |
| B. Riley Securities | Maintained | Buy | $52.00 from $58.00 | Mar 13, 2026 |
| Roth Capital | Maintained | Buy | $74.00 | Jan 20, 2026 |
| William Blair | Initiated Coverage | Outperform | — | Jan 13, 2026 |
| Roth Capital | Maintained | Buy | $74.00 from $64.00 | Oct 1, 2025 |
| Roth Capital | Initiated Coverage | Buy | $64.00 | Aug 20, 2025 |
| B. Riley Securities | Maintained | Buy | $28.00 from $30.00 | Apr 22, 2025 |
| B. Riley Securities | Initiated Coverage | Buy | $30.00 | Oct 10, 2024 |
| ThinkEquity | Initiated Coverage | Buy | $20.00 | Jun 24, 2024 |
Frequently asked questions
What is the latest analyst rating on IPX?
On Jun 5, 2026, BTIG maintained IperionX at Buy with a price target of $55.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.